Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Singulair And Suicidality: FDA Finds No Immediate Link, But Review Continues

Executive Summary

FDA is continuing to review a possible relationship between the use of Merck's Singulair (montelukast) and an increased risk of suicidality despite finding no association so far between leukotriene pathway drugs and mood behaviors

You may also be interested in...



FDA Suicidality Reassessments Will Be Made At Division Level, Not Through Guidance

Decisions on whether to add drugs or classes of drugs to a list FDA has published of investigational products that need suicidality assessments will be made at the division level, the agency says.

FDA Suicidality Reassessments Will Be Made At Division Level, Not Through Guidance

Decisions on whether to add drugs or classes of drugs to a list FDA has published of investigational products that need suicidality assessments will be made at the division level, the agency says.

FDA MedWatch Alert Warns Of Possible Suicide Risk With Singulair

Agency needs nine months to review post-marketing data on Merck asthma drug due to the complexity of the information.

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel